- Denmark extends lockdown until 17 January
- England may face tougher ‘tier 5’ Covid restrictions
- Spain to keep registry of people who refuse Covid vaccine
- The lost year: could Covid lockdown have helped save the planet?
- South Africa bans alcohol sales to help curb spread of virus
- See all our coronavirus coverage
The first study of the safety and effectiveness of a coronavirus vaccine in Iran began on Tuesday, state TV reported, with dozens due to receive the domestically developed shot even as details about its production remained slim.
The vaccine, the first in the country to reach human trials, is produced by Shifa Pharmed, part of a state-owned pharmaceutical conglomerate known as Barekat.
I am happy that the scientific process went ahead in a proper way,” said Tayebeh Mokhber, daughter of the Setad Foundation chairman, who was the first to get jabbed. “I hope the conclusion will be health for our people.”